Influence of Calcium Pattern on Plaque Modification Achieved With Intracoronary Lithotripsy

March 4, 2024 updated by: Nieves Gonzalo, Fundacion Investigacion Interhospitalaria Cardiovascular

Calcified coronary artery disease is a frequently encountered problem that can lead to poorer outcomes for patients undergoing PCI. Recently, intravascular lithotripsy has become available for the treatment of callcified coronary artery disease. The effect of intravascular lithotripsy on varying calcium patterns has not been adequately explored.

This is an investigator initiated, open label, non-blinded, observational study involving a number of centers in Spain examining the effect of intravasuclar lithotripsy in varying calcium patterns. 100 patients wll be enrolled. Optical coherence tomography will be used to assess the effect of intravascular lithotripsy on varying calcium patterns (concentric, eccentric and nodular).

Study Overview

Detailed Description

Calcified coronary artery disease continues to present a challenge for Interventional Cardiologists. Moderate calcification is found in over 25% of coronary artery lesions planned for percutaneous coronary intervention (PCI). Outcomes for patients undergoing PCI to calcified lesions have been shown to be consistently poorer than in non-calcified lesions. Recently, intravascular lithotripsy has become available for the treatment of calcified coronary artery disease. The effect of intravascular lithotripsy on varying calcium patterns has not been adequately explored.

This is an investigator initiated, open label, non-blinded, observational study involving a number of centers in Spain. Patients with an indication of PCI and with a significant calcium burden requiring modification will be invited to participate. PCI procedures will be performed via either radial or femoral access as deemed appropriate by the operator and in accordance with local protocols. Intravascular imaging using OCT will be performed prior to calcium modification to define the pattern of calcium, after calcium modification to assess the effectiveness of IVL therapy and after stent implantation to assess stent expansion.

Study Type

Observational

Enrollment (Actual)

96

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Madrid, Spain, 28040
        • Hospital Clinico San Carlos

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

N/A

Sampling Method

Non-Probability Sample

Study Population

Patients with calcified coronary artery disease planned for percutaneous coronary intervention and stenting with the use of intravascular lithotripsy for calcium modification prior to stenting.

Description

Inclusion Criteria:

  • Patients >18 years of age
  • Patients with an indication for PCI (ischemic symptoms or evidence of myocardial ischemia (inducible or spontaneous) in the presence of >50% de novo severely calcified coronary stenosis that requires IVL treatment.

Exclusion Criteria:

  • Patients unwilling or unable to sign informed consent for the procedure
  • Patients with severe peripheral vascular disease limiting vascular access to the extent that it is unsafe to perform the procedure
  • Patients with severe renal dysfunction (eGFR <15mls/min and not receiving dialysis)
  • Treatment of vessels < 2.5mm diameter which are not amenable to IVL treatment or OCT assessment.
  • Treatment of lesions located very distally in the coronary vessel where the OCT catheter may not reach.
  • Inability to cross the lesion with the OCT catheter due to very severe stenosis or severe vessel tortuosity.
  • Ostial left main stem or right coronary artery lesions which may be difficult to visualise by OCT
  • Patients requiring concomitant use of rotational or orbital atherectomy of LASER.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Circumferential calcification
Patients with circumferential pattern of coronary artery calcification by OCT (Optical coherence tomography) assessment (arc of calcium >180 degrees)
Intracoronary lithotripsy involves the use of sonic pressure waves generated from emitters enclosed within a balloon delivery system. The generated sonic waves act to fracture calcium within the coronary artery wall.
Eccentric calcification
Patients with an eccentric pattern of coronary artery calcification by OCT (Optical coherence tomography) assessment (arc of calcium <180 degrees)
Intracoronary lithotripsy involves the use of sonic pressure waves generated from emitters enclosed within a balloon delivery system. The generated sonic waves act to fracture calcium within the coronary artery wall.
Nodular calcification
Patients with calcium nodules identified by OCT (Optical coherence tomography) assessment
Intracoronary lithotripsy involves the use of sonic pressure waves generated from emitters enclosed within a balloon delivery system. The generated sonic waves act to fracture calcium within the coronary artery wall.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Percentage of lesions with Calcium Fractures
Time Frame: At the time of percutaneous coronary intervention
Percentage of lesions showing calcium modification (fractures) after intravascular lithotripsy (IVL) in nodular eccentric and concentric calcium patterns
At the time of percutaneous coronary intervention

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of calcium fractures
Time Frame: At the time of percutaneous coronary intervention
Number of calcium fractures visible on OCT after IVL treatment
At the time of percutaneous coronary intervention
Number of quadrants with calcium fractures
Time Frame: At the time of percutaneous coronary intervention
Number of quadrants with calcium fractures after IVL treatment as assessed by OCT
At the time of percutaneous coronary intervention
Calcium modification in eccentric versus concentric calcium
Time Frame: At the time of percutaneous coronary intervention
Percentage of lesions with calcium arc <180 versus >180 degrees with fractures as assessed by OCT
At the time of percutaneous coronary intervention
Stent expansion
Time Frame: At the time of percutaneous coronary intervention
Percentage stent expansion in patients with and without calcium modification (fractures) after application of IVL
At the time of percutaneous coronary intervention
Stent symmetry
Time Frame: At the time of percutaneous coronary intervention
Stent symmetry index in patients with and without calcium modification (fractures) after IVL application
At the time of percutaneous coronary intervention
Stent symmetry
Time Frame: At the time of percutaneous coronary intervention
Stent symmetry index in patients with concentric versus eccentric calcification
At the time of percutaneous coronary intervention

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 1, 2020

Primary Completion (Actual)

May 1, 2022

Study Completion (Actual)

May 1, 2022

Study Registration Dates

First Submitted

January 5, 2021

First Submitted That Met QC Criteria

January 5, 2021

First Posted (Actual)

January 7, 2021

Study Record Updates

Last Update Posted (Estimated)

March 6, 2024

Last Update Submitted That Met QC Criteria

March 4, 2024

Last Verified

March 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Coronary Artery Disease

Clinical Trials on Intracoronary lithotripsy

Subscribe